ReadOn Therapeutics gGmbh

📍 Munich, Germany🗓 Founded 2026👥 3 employees
Biotechnology Research🌐 readontx.com
Website LinkedIn
ReadOn Therapeutics is a non-profit biotechnology organisation focused on developing readthrough therapeutics for Epidermolysis Bullosa (EB), with an initial focus on dystrophic EB caused by nonsense mutations. Our vision is to make nonsense read-through a validated, scaleable therapeutic category, developing functional cure for EB patients and hundreds of rare diseases. We operate at the intersection of translational science, rare disease research, and patient-centred drug development, working collaboratively with researchers, clinicians, biotech partners, and the EB community to accelerate progress toward meaningful treatments. ReadOn Therapeutics is based in Munich, Germany.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2026
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was ReadOn Therapeutics gGmbh founded?
ReadOn Therapeutics gGmbh was founded in 2026.
What industry is ReadOn Therapeutics gGmbh in?
ReadOn Therapeutics gGmbh operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ReadOn Therapeutics gGmbh based?
ReadOn Therapeutics gGmbh is headquartered in Munich, Germany.